News
Chronic diseases to drive MRI systems market 2031 expansion to $9.68b
Chronic diseases to drive MRI systems market 2031 expansion to $9.68b
The ultra-high-field MRI systems segment is expected to have the highest CAGR.
Rising chronic diseases drive $19t global healthcare services market by 2034
The market was valued at $9.14t in 2025.
HKU develop RNA 'cut-and-patch' tool for treating neurodegenerative diseases
It enables precise removal and replacement of faulty RNA segments without changing DNA.
AI osteoporosis screening market to more than double by 2036
This comes amidst higher demand for preventive healthcare and rising cases.
Oil shock hits Asia’s drugmakers as petrochemical crunch squeezes supply chains
Almost all pharmaceutical raw materials trace back to petrochemical origins.
IHH Healthcare core profit up 3% in 2025 as revenue hits $6.6b
Core revenue rose 18%.
Biomarkers market set for 11% CAGR on early detection push
The market was valued at $26.48b in 2025.
Rising chronic diseases drive growth in medical membrane market
Increasing use of dialysis and biopharmaceutical applications is boosting adoption.
Immunotherapy boom drives demand for PET/CT imaging in Australia’s oncology sector
Australia accounted for 2% of the APAC PET/CT market in 2025.
Seoul hospital, Harvard replace static AI testing with hospital simulator
They tested AI impact on patient outcomes and hospital operations.
SNUH installs ‘smart hearing loop’ system for hearing-impaired patients
It has been installed in eight units across five key hospital areas.
Rising osteoarthritis cases drive expansion of India’s hip implant market
India held about 8% share of APAC hip replacement market in 2025
SCRS and Medtronic Singapore sign MoU to boost colorectal surgery training
Focus includes minimally invasive and technology-assisted surgical techniques.
KPJ Healthcare profit rises 22% in Q1 amidst system shift
The group's revenue increased 9% to $265.8m.
Agilent and Singapore’s NATi sign research partnership on oligonucleotide therapeutics
The work focuses on oligonucleotide therapeutics.
Hong Kong healthcare pushes pricing clarity, trials, and biotech capacity
Six in 10 patients delay treatment due to cost anxiety.
Acute myocardial infarction market hits $1.60b in 2025 across leading markets
Seven major markets record 1.5-million heart attack cases in 2025.
Most Read
1. Indonesia bets on stem cell rules to boost longevity care 2. IHH Singapore goes preventive with new Healthspan programme 3. Health ministry unveils homegrown AI model built for patients 4. Australia funds $10.4m RNA lung therapy trials at Monash 5. AI in pharma market to hit $28.6b by 2034 on drug discovery pushResource Center
Read Here
Advertise
Sign Up
Partner Events
Event News
Demand was strong for AI-driven and digital healthcare solutions.
Commentary
AI drug discovery, GLP-1, and the next wave of Hong Kong biotech listings
Beyond symptom control: Redefining IMID care in Malaysia
How decentralised clinical trials can unlock Asia's research potential